Benzinga's Top Upgrades

Analysts at Jefferies upgraded Abbott Laboratories ABT from Hold to Buy. The price target for Abbott Laboratories has been raised to $55. Abbott Laboratories shares closed at $45.30 on Friday. Analysts at Keefe Bruyette & Woods upgraded Medley Capital Corp MCC from Market Perform to Outperform. The price target for Medley Capital has been lowered from $10.50 to $9. Medley Capital shares closed at $7.58 on Friday. Morgan Stanley upgraded Ternium SA (ADR) TX from Equal-weight to Overweight. The price target for Ternium has been lowered to $20. Ternium shares closed at $13.13 on Friday. Barclays upgraded Norfolk Southern Corp. NSC from Underweight to Equal-weight. The price target for Norfolk Southern has been raised from $76 to $95. Norfolk Southern shares closed at $92.09 on Friday. Analysts at Deutsche Bank upgraded Eli Lilly and Co LLY from Hold to Buy. The price target for Eli Lilly has been raised to $99. Eli Lilly shares closed at $86.61 on Friday. Analysts at KeyBanc upgraded Public Storage PSA from Underweight to Sector Weight. Public Storage shares closed at $241.90 on Friday. Analysts at UBS upgraded American Electric Power Company Inc AEP from Neutral to Buy. The price target for American Electric Power has been raised from $61 to $62. American Electric Power shares closed at $55.84 on Friday. Stifel Nicolaus upgraded Isle of Capri Casinos ISLE from Hold to Buy. Isle of Capri Casinos shares closed at $14.72 on Friday. Nomura upgraded RenaissanceRe Holdings Ltd. RNR from Reduce to Neutral.. RenaissanceRe Holdings shares closed at $113.59 on Friday. Jefferies upgraded AbbVie Inc ABBV from Hold to Buy. The price target for AbbVie has been raised from $49 to $55. AbbVie shares closed at $57.19 on Friday.